These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4660365)

  • 1. [Evaluation of tolerability of an anticholera vaccine].
    Del Vecchio V; D'Arca SU; Melino C
    Nuovi Ann Ig Microbiol; 1972; 23(1):1-8. PubMed ID: 4660365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticholera vaccines and vaccination].
    Ivanoff B; Chaignat CL
    Bull Soc Pathol Exot; 2002 Dec; 95(5):355-8. PubMed ID: 12696375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new inactivated oral cholera vaccine.
    Oberdoerster F; Thilo W
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):213-5. PubMed ID: 4440525
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholera vaccine. Recommendation on immunization practices.
    Ann Intern Med; 1968 Oct; 69(4):783-4. PubMed ID: 5687532
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticholera vaccination by means of the intradermal pedojet. Clinical and immunologic response (results of a Senegalese experiment)].
    Diop Mar I; Sarrat H; Robin Y; Oudart ; Rey M
    Bull Soc Pathol Exot Filiales; 1971; 64(5):663-72. PubMed ID: 5172702
    [No Abstract]   [Full Text] [Related]  

  • 6. [Controlled results of the oral anticholera vaccine from the Institut Pasteur during the Shaba-Zaire epidemic in 1983].
    Dodin A; Masengo B; Loucq C
    C R Acad Sci III; 1984; 299(7):205-7. PubMed ID: 6435818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera and typhoid vaccine. The current state of play.
    Cohen J
    Aust Fam Physician; 1997 Aug; 26(8):943-6. PubMed ID: 9267060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intradermal inoculation in anti-cholera vaccination].
    Gallut J
    Med Trop (Mars); 1971; 31(1):124-6. PubMed ID: 5576842
    [No Abstract]   [Full Text] [Related]  

  • 9. [Seroprotection of chick embryo used as indicator test for the effectiveness of cholera vaccine].
    Chirescu N; Popescu G; Popovici M
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):545-7. PubMed ID: 5519923
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of anticholera vaccination on associated anti-yellow fever immunization].
    Gateff C; Le Gonidec G; Boche R; Sarrat P; Lemarinier G; Monchicourt D; Labusquière R
    Bull Soc Pathol Exot Filiales; 1973; 66(2):258-66. PubMed ID: 4801953
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse events after oral vaccination against cholera with CVD103-HgR.
    Wiedermann G; Kollaritsch H; Jeschko E; Kundi M; Herzog C; Wegmüller B
    Wien Klin Wochenschr; 1998 May; 110(10):376-8. PubMed ID: 9654693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
    Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
    Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurological complications of cholera vaccination in childhood (epidemiological studies, clinical aspects, follow-up)].
    Giordano GG; Militerni R; Madia S
    Pediatria (Napoli); 1978 Jun; 86(2):221-31. PubMed ID: 704226
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunity and cholera vaccines in relation to the health problem of the prevention of cholera in Italy].
    Collotti C; Vella L; Vicari G
    Ann Ist Super Sanita; 1971; 7(4):501-12. PubMed ID: 5151222
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholera vaccine: reasons for acceptability.
    Neogy KN
    J Indian Med Assoc; 1972 Feb; 58(4):132-3. PubMed ID: 5021713
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefit versus risk factors in cholera and typhoid immunization.
    Joó I
    Dev Biol Stand; 1979; 43():47-52. PubMed ID: 520686
    [No Abstract]   [Full Text] [Related]  

  • 19. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF; Dietrich G; Favre D
    Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serologic changes induced by anticholera vaccine].
    Cavaliere T; D'Isanto R; Palmieri A
    Acta Neurol (Napoli); 1974; 29(5):503-4. PubMed ID: 4451166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.